The neutrophil count was approximately 2-fold higher in severe compared to moderate COVID-19, while the increase in serum S100A12 was 1.5-fold, suggesting that S100A12 production by neutrophils is impaired in severe disease. This evidence concerns the gene S100A12 and COVID-19.